Research News and Research

RSS

Cortex third quarter net loss decreases to $528,000

Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of approximately $528,000, or $0.01 per share, for the quarter ended September 30, 2010, compared with a net loss applicable to common stock of approximately $3,243,000 or $0.06 per share, for the prior year quarter.

12 Nov 2010

IBEC researchers discover new group of interacting partners for myelin-associated receptors

It's known that the development of neuronal diseases such as multiple sclerosis and Alzheimer's disease is connected with the levels of myelin - an insulating substance around nerve fibres - in the body, although the actual causes of these conditions remain unknown. Now researchers at IBEC have discovered a new group of interacting partners for myelin-associated receptors, which could shed light on the significance of imbalanced production or modifications of the substance.

12 Nov 2010

Amorfix second quarter net loss decreases to $25,728

Amorfix Life Sciences, a product development company focused on the development of diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the three and six months ended September 30, 2010.

12 Nov 2010

CytomX awarded $488,000 as grant under QTDP Program

CytomX Therapeutics, a biotechnology company focused on the development of proteolytically activated antibodies, today announced the receipt of two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The grants are directed toward the company's lead preclinical programs targeting colon, head and neck, pancreatic and triple-negative breast cancers and glioblastoma multiforme (GBM).

12 Nov 2010

Soligenix third quarter revenues increase to $861,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the third quarter of 2010.

12 Nov 2010

Pro-Pharmaceuticals third quarter net loss decreases to $1,899,000

Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.

12 Nov 2010

Transgenomic awarded $1,070,453 grant under Patient Protection and Affordable Care Act

Transgenomic, Inc. today announced that it has been awarded a research and development grant totaling $1,070,453.32 from the U.S. government under HR: 3590 – Patient Protection and Affordable Care Act (the "Act") in immediately available funds. This is among the largest awards for any one company under the Act.

12 Nov 2010

NovaBay third quarter net loss increases to $1.6 million

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, has reported third quarter financial results and highlighted the clinical progress of its in-house programs.

12 Nov 2010

EntreMed reports $2.1 million net loss for third quarter 2010

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported results for the three- and nine-month periods ending September 30, 2010.

12 Nov 2010

First Edition: November 12, 2010

Today's headlines include examinations of Medicaid and state budget issues as well as the next round of the congressional health overhaul fight.

12 Nov 2010

Alcohol consumption among young Spaniards linked to night-time violence

Night-time violence among young Spaniards is becoming ever more common, according to a research study carried out by the European Institute of Studies on Prevention. The study shows that 5.2% of young people carry weapons when they go out at night, 11.6% have been attacked or threatened, and 23% have got into a fight at some time.

12 Nov 2010

Community-wide prevention strategy helps reduce student drinking

Heavy drinking among college students results in over 1800 deaths each year, as well as 590,000 unintentional injuries, almost 700,000 assaults and more than 97,000 victims of sexual assaults. In a new study published in the December issue of the American Journal of Preventive Medicine, researchers report on the results of the Safer California Universities study, a successful community-wide prevention strategy targeted at off-campus settings. This is one of the first studies to focus on the total environment rather than on prevention aimed at individuals.

12 Nov 2010

Clemson scientists granted $1.2 million grant to study interaction of plutonium with soil

Environmental scientists at Clemson University have received a three-year, $1.2 million grant from the U.S. Department of Energy to study how plutonium, a byproduct of used nuclear fuel, interacts with soil.

12 Nov 2010

Plant-based respiratory allergies on the rise due to climate change

Bad news for 35 million allergy sufferers - ragweed, fungal spores and poison ivy are thriving due to rising carbon dioxide levels. At the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Phoenix, Nov. 11-16, allergists and scientists discussed the effects of rising CO2 levels and a changing climate on plant biology and public health.

12 Nov 2010

Five Grand Challenges for Earth system

The international scientific community has identified five Grand Challenges that, if addressed in the next decade, will deliver knowledge to enable sustainable development, poverty eradication, and environmental protection in the face of global change. The Grand Challenges for Earth system science, published today, are the result of broad consultation as part of a visioning process spearheaded by the International Council for Science (ICSU) in cooperation with the International Social Science Council (ISSC).

12 Nov 2010

Bioethics in pharmaceutical industry, regenerative medicine, and public health

To celebrate 40 years of pioneering bioethics publication, the Hastings Center Report, the world's first bioethics journal, looked to the future, asking young scholars to write about what the next generation of bioethicists should take up. Out of 195 compelling submissions, four of the best essays were selected for publication in the November-December issue.

12 Nov 2010

Eight students to receive Hartford Doctoral Fellowship in geriatric social work

Eight outstanding students have been chosen as the newest recipients of the prestigious Hartford Doctoral Fellowship in geriatric social work. The program is funded by the John A. Hartford Foundation, administered by The Gerontological Society of America, and directed by James Lubben, DSW, MPH.

12 Nov 2010

Working of doctor's office

While undergoing an X-ray, Holly Gage, of Bowmansville, Pa., shared details about her medical concerns with the technician and asked questions about the results, only to find out the technician wasn't permitted to answer them.

12 Nov 2010

New MoDEL database to study biology of proteins

After four years of conducting intensive calculations in the supercomputer MareNostrum at the Barcelona Supercomputing Center, scientists headed by Modesto Orozco at the Institute for Research in Biomedicine (IRB Barcelona) have presented the world's largest data base on protein motions. Called MoDEL, this new database holds more than 1,700 proteins and is partially accessible through Internet to researchers worldwide. MoDEL has been developed to study the basic biology of proteins and to accelerate and facilitate the design of new pharmaceutical agents.

12 Nov 2010

DS Waters extends partnership with Susan G. Komen for the Cure

DS Waters of America, Inc., a leader in home and office bottled water, water filtration and office coffee delivery service, today announced it has extended its current partnership with Susan G. Komen for the Cure until January 30, 2016, extending the parties' prior commitment by an additional five years. The modified agreement also adds water filtration to the list of products associated with Komen for the Cure.

12 Nov 2010